301 related articles for article (PubMed ID: 16669860)
1. Pharmacokinetics of the calcium-channel blocker diltiazem after a single intravenous dose in horses.
Schwarzwald CC; Sams RA; Bonagura JD
J Vet Pharmacol Ther; 2006 Jun; 29(3):165-71. PubMed ID: 16669860
[TBL] [Abstract][Full Text] [Related]
2. Influence of honey on orally and intravenously administered diltiazem kinetics in rabbits.
Koumaravelou K; Adithan C; Shashindran CH; Asad M; Abraham BK
Indian J Exp Biol; 2002 Oct; 40(10):1164-8. PubMed ID: 12693698
[TBL] [Abstract][Full Text] [Related]
3. Effect of diltiazem on the pharmacokinetics of MPC-1304, a new calcium channel blocker.
Ohashi K; Sudo T; Sakamoto K; Tateishi T; Fujimura A; Kumagai Y; Shiga T; Ebihara A
Int J Clin Pharmacol Ther Toxicol; 1992 Aug; 30(8):271-4. PubMed ID: 1526689
[TBL] [Abstract][Full Text] [Related]
4. Gender related pharmacokinetics of diltiazem in healthy subjects.
Sáenz-Campos D; Bayés MC; Martin S; Barbanoj MJ; Jané F
Int J Clin Pharmacol Ther; 1995 Jul; 33(7):397-400. PubMed ID: 7582396
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and clinical effects of pirfenidone administered intravenously in horses.
Braim AE; Macdonald MH; Bruss ML; Stanley SD; Giri JK; Giri SN
Am J Vet Res; 2008 Jul; 69(7):952-60. PubMed ID: 18593250
[TBL] [Abstract][Full Text] [Related]
6. The kinetic profiles of amlodipine and of a sustained release form of diltiazem.
Fourtillan JB; Ingrand I; Decourt JP; Istin B; Girault J
Therapie; 1998; 53(2):121-6. PubMed ID: 9773111
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and effects of aminorex in horses.
Soma LR; Rudy JA; Uboh CE; Xu F; Snapp HM
Am J Vet Res; 2008 May; 69(5):675-81. PubMed ID: 18447801
[TBL] [Abstract][Full Text] [Related]
8. Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteers.
Christensen H; Asberg A; Holmboe AB; Berg KJ
Eur J Clin Pharmacol; 2002 Nov; 58(8):515-20. PubMed ID: 12451428
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of multiple-dose administration of eltenac in horses.
Dyke TM; Sams RA; Thompson KG; Ashcraft SM
Am J Vet Res; 1998 Nov; 59(11):1447-50. PubMed ID: 9829405
[TBL] [Abstract][Full Text] [Related]
10. HPLC determination of diltiazem in human plasma and its application to pharmacokinetics in humans.
Li K; Zhang X; Zhao F
Biomed Chromatogr; 2003 Dec; 17(8):522-5. PubMed ID: 14648609
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and plasma concentrations of acetylsalicylic acid after intravenous, rectal, and intragastric administration to horses.
Broome TA; Brown MP; Gronwall RR; Casey MF; Meritt KA
Can J Vet Res; 2003 Oct; 67(4):297-302. PubMed ID: 14620867
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of tramadol in horses after intravenous, intramuscular and oral administration.
Shilo Y; Britzi M; Eytan B; Lifschitz T; Soback S; Steinman A
J Vet Pharmacol Ther; 2008 Feb; 31(1):60-5. PubMed ID: 18177320
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic effects and pharmacokinetic profile of a long-term continuous rate infusion of racemic ketamine in healthy conscious horses.
Lankveld DP; Driessen B; Soma LR; Moate PJ; Rudy J; Uboh CE; van Dijk P; Hellebrekers LJ
J Vet Pharmacol Ther; 2006 Dec; 29(6):477-88. PubMed ID: 17083451
[TBL] [Abstract][Full Text] [Related]
14. Enhanced diltiazem bioavailability after oral administration of diltiazem with quercetin to rabbits.
Choi JS; Li X
Int J Pharm; 2005 Jun; 297(1-2):1-8. PubMed ID: 15907592
[TBL] [Abstract][Full Text] [Related]
15. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of difloxacin after intravenous, intramuscular, and intragastric administration to horses.
Fernández-Varón E; Cárceles CM; Marín P; Martos N; Escudero E; Ayala I
Am J Vet Res; 2006 Jun; 67(6):1076-81. PubMed ID: 16740105
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of epsilon-aminocaproic acid in horses.
Ross J; Dallap BL; Dolente BA; Sweeney RW
Am J Vet Res; 2007 Sep; 68(9):1016-21. PubMed ID: 17764418
[TBL] [Abstract][Full Text] [Related]
18. Steady-state dose proportionality of a once-a-day sustained-release diltiazem hydrochloride formulation in healthy subjects.
Ziemniak J; Colligon I; Heald D
Clin Ther; 1992; 14(2):158-65. PubMed ID: 1611640
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics of orbifloxacin in the horse following oral and intravenous administration.
Davis JL; Papich MG; Weingarten A
J Vet Pharmacol Ther; 2006 Jun; 29(3):191-7. PubMed ID: 16669863
[TBL] [Abstract][Full Text] [Related]
20. Effect of atorvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats.
Hong SP; Chang KS; Choi DH; Choi JS
Arch Pharm Res; 2007 Jan; 30(1):90-5. PubMed ID: 17328247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
